MetaCap

Alcon Inc. (ALC)

NYSE: ALCHealth CareOphthalmic GoodsUSD

74.31-0.19 (-0.26%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ALC stock chart

Technical analysis

Key statistics

All statistics
Market cap
$35.70B
Dividend yield
0.48% ($0.353)
Ex-dividend date
May 5, 2026
52-week range
61.84 – 87.64
Day range
74.10 – 75.04
Volume / Avg
3.42M / 2.01M
Beta
—

52-week range

$61.84$87.64

ALC stock today

Shares of Alcon (ALC) finished lower on Nov 20 at $74.31, a drop of 0.26% or $0.19 per share, versus the S&P 500's 3.70% decline. At this level, ALC sits in the middle of its 52-week range of $61.84 to $87.64: 15.2% below the high, set on Feb 26, 2026 and 20.2% above the low. ALC is down 5.7% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 3.0%.

At 54.2x trailing earnings, Alcon trades above the peer-group median of 20.3x. Its forward P/E of 19.1x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Alcon pays an annual dividend of $0.353 per share, a 0.48% yield at the current price.

Summary generated from market data by MetaCap's automated system. Methodology

About Alcon

Company profile

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care.

Industry
Ophthalmic Goods
CEO
Mr. David J. Endicott
Headquarters
Geneva, TX
Employees
25,000
IPO year
2019
Website
alcon.com

Financial highlights

Full financials

In fiscal 2025, Alcon generated $10.40 billion in revenue, up 4.9% from fiscal 2024, its 5th consecutive year of revenue growth. Net income was $980.0 million (-3.7% year over year), for a net margin of 9.4% versus a median of 4.5% in the prior 5 years. Gross margin was 55.2% (down from 55.6%) and operating margin 13.1%.

Alcon annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$10.40B$9.91B$9.46B$8.72B$8.29B
Growth+4.94%+4.82%+8.47%+5.14%+21.34%
Net income$980.00M$1.02B$974.00M$335.00M$376.00M
EPS (diluted)$1.98$2.05$1.96$0.68$0.76

Analyst forecast

Forecast

Consensus (27 analysts)

buy

Avg. price target

$81.27+9.37%

  • Strong buy 3
  • Buy 17
  • Hold 6
  • Sell 0
  • Strong sell 1

Target range

Low $63.00High $103.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 10, 2026
EPS actual vs est.
$0.79 vs $0.89
Surprise
-11.24%

Dividends

Dividend history
Annual dividend
$0.353
Last payment
$0.358
Ex-dividend date
May 5, 2026

ALC news

All ALC news

Alcon peers

Health Care sector
ALC peer companies
CompanyPrice% ChgMarket capCompare
COOThe Cooper Companies Inc.58.88-2.40%$11.20Bvs ALC
BLCOBausch + Lomb Corporation19.38-6.33%$6.93Bvs ALC
WRBYWarby Parker Inc. Class A23.12-4.19%$2.87Bvs ALC
EYENational Vision Holdings Inc.16.72-1.70%$1.31Bvs ALC
STAASTAAR Surgical Company24.22-3.24%$1.22Bvs ALC
RXSTRxSight Inc.4.47-3.04%$187.42Mvs ALC
LUCYInnovative Eyewear Inc.0.7025-0.07%$6.12Mvs ALC

Indexes, lists and sector

Alcon stock FAQ

What is Alcon's stock price today?

ALC last traded at $74.31 as of Nov 20, 4:00 PM EST, down 0.26% on the day. Prices are delayed at least 15 minutes.

Does Alcon pay a dividend?

Yes. Alcon pays $0.353 per share annually, a 0.48% yield. The most recent dividend of $0.358 had an ex-dividend date of May 5, 2026.

What is ALC's P/E ratio?

ALC trades at a trailing P/E ratio of 54.24 and a forward P/E of 19.05, compared with a median of 20.3 for its closest peers.

Who is Alcon's CEO?

Mr. David J. Endicott is the chief executive officer of Alcon Inc., which has about 25,000 employees.

What is the ALC 52-week high?

The 52-week high for ALC is $87.64 and the 52-week low is $61.84. The stock is currently 15.2% below its high.

Compare ALC